Global BCG and Tuberculosis Vaccine Market Research Report 2025(Status and Outlook)
Report Overview
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guйrin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
This report provides a deep insight into the global BCG and Tuberculosis Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global BCG and Tuberculosis Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the BCG and Tuberculosis Vaccine market in any manner.
Global BCG and Tuberculosis Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Market Segmentation (by Type)
Immune Vaccine
Therapy Vaccine
Market Segmentation (by Application)
Self-Procurement
UNICEF
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the BCG and Tuberculosis Vaccine Market
Overview of the regional outlook of the BCG and Tuberculosis Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the BCG and Tuberculosis Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guйrin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
This report provides a deep insight into the global BCG and Tuberculosis Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global BCG and Tuberculosis Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the BCG and Tuberculosis Vaccine market in any manner.
Global BCG and Tuberculosis Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Market Segmentation (by Type)
Immune Vaccine
Therapy Vaccine
Market Segmentation (by Application)
Self-Procurement
UNICEF
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the BCG and Tuberculosis Vaccine Market
Overview of the regional outlook of the BCG and Tuberculosis Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the BCG and Tuberculosis Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of BCG and Tuberculosis Vaccine
1.2 Key Market Segments
1.2.1 BCG and Tuberculosis Vaccine Segment by Type
1.2.2 BCG and Tuberculosis Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL BCG AND TUBERCULOSIS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global BCG and Tuberculosis Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global BCG and Tuberculosis Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL BCG AND TUBERCULOSIS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global BCG and Tuberculosis Vaccine Product Life Cycle
3.3 Global BCG and Tuberculosis Vaccine Sales by Manufacturers (2020-2025)
3.4 Global BCG and Tuberculosis Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 BCG and Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global BCG and Tuberculosis Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers BCG and Tuberculosis Vaccine Manufacturing Sites, Area Served, Product Type
3.8 BCG and Tuberculosis Vaccine Market Competitive Situation and Trends
3.8.1 BCG and Tuberculosis Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest BCG and Tuberculosis Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BCG AND TUBERCULOSIS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 BCG and Tuberculosis Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BCG AND TUBERCULOSIS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global BCG and Tuberculosis Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to BCG and Tuberculosis Vaccine Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL BCG AND TUBERCULOSIS VACCINE MARKET BY REGION
6.1 Global BCG and Tuberculosis Vaccine Market Size by Region
6.1.1 Global BCG and Tuberculosis Vaccine Market Size by Region
6.1.2 Global BCG and Tuberculosis Vaccine Market Size Market Share by Region
6.2 Global BCG and Tuberculosis Vaccine Sales by Region
6.2.1 Global BCG and Tuberculosis Vaccine Sales by Region
6.2.2 Global BCG and Tuberculosis Vaccine Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America BCG and Tuberculosis Vaccine Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America BCG and Tuberculosis Vaccine Market Size by Type
7.3 North America BCG and Tuberculosis Vaccine Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe BCG and Tuberculosis Vaccine Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe BCG and Tuberculosis Vaccine Market Size by Type
8.3 Europe BCG and Tuberculosis Vaccine Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific BCG and Tuberculosis Vaccine Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific BCG and Tuberculosis Vaccine Market Size by Type
9.3 Asia-Pacific BCG and Tuberculosis Vaccine Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America BCG and Tuberculosis Vaccine Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America BCG and Tuberculosis Vaccine Market Size by Type
10.3 South America BCG and Tuberculosis Vaccine Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Type
11.3 Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Application
12 BCG AND TUBERCULOSIS VACCINE MARKET PRODUCTION BY REGION
12.1 Global Production of BCG and Tuberculosis Vaccine by Region(2020-2025)
12.2 Global BCG and Tuberculosis Vaccine Revenue Market Share by Region (2020-2025)
12.3 Global BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America BCG and Tuberculosis Vaccine Production
12.4.1 North America BCG and Tuberculosis Vaccine Production Growth Rate (2020-2025)
12.4.2 North America BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe BCG and Tuberculosis Vaccine Production
12.5.1 Europe BCG and Tuberculosis Vaccine Production Growth Rate (2020-2025)
12.5.2 Europe BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan BCG and Tuberculosis Vaccine Production (2020-2025)
12.6.1 Japan BCG and Tuberculosis Vaccine Production Growth Rate (2020-2025)
12.6.2 Japan BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China BCG and Tuberculosis Vaccine Production (2020-2025)
12.7.1 China BCG and Tuberculosis Vaccine Production Growth Rate (2020-2025)
12.7.2 China BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
13 BCG AND TUBERCULOSIS VACCINE MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2020-2033)
13.3 Global BCG and Tuberculosis Vaccine Market Size Market Share by Type (2020-2033)
13.4 Global BCG and Tuberculosis Vaccine Price by Type (2020-2033)
14 BCG AND TUBERCULOSIS VACCINE MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global BCG and Tuberculosis Vaccine Market Sales by Application (2020-2033)
14.3 Global BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2033)
14.4 Global BCG and Tuberculosis Vaccine Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Merck
15.1.1 Merck Basic Information
15.1.2 Merck BCG and Tuberculosis Vaccine Product Overview
15.1.3 Merck BCG and Tuberculosis Vaccine Product Market Performance
15.1.4 Merck Business Overview
15.1.5 Merck SWOT Analysis
15.1.6 Merck Recent Developments
15.2 Japan BCG Lab
15.2.1 Japan BCG Lab Basic Information
15.2.2 Japan BCG Lab BCG and Tuberculosis Vaccine Product Overview
15.2.3 Japan BCG Lab BCG and Tuberculosis Vaccine Product Market Performance
15.2.4 Japan BCG Lab Business Overview
15.2.5 Japan BCG Lab SWOT Analysis
15.2.6 Japan BCG Lab Recent Developments
15.3 Serum Institute of India
15.3.1 Serum Institute of India Basic Information
15.3.2 Serum Institute of India BCG and Tuberculosis Vaccine Product Overview
15.3.3 Serum Institute of India BCG and Tuberculosis Vaccine Product Market Performance
15.3.4 Serum Institute of India Business Overview
15.3.5 Serum Institute of India SWOT Analysis
15.3.6 Serum Institute of India Recent Developments
15.4 AJ Vaccines
15.4.1 AJ Vaccines Basic Information
15.4.2 AJ Vaccines BCG and Tuberculosis Vaccine Product Overview
15.4.3 AJ Vaccines BCG and Tuberculosis Vaccine Product Market Performance
15.4.4 AJ Vaccines Business Overview
15.4.5 AJ Vaccines Recent Developments
15.5 BioFarma
15.5.1 BioFarma Basic Information
15.5.2 BioFarma BCG and Tuberculosis Vaccine Product Overview
15.5.3 BioFarma BCG and Tuberculosis Vaccine Product Market Performance
15.5.4 BioFarma Business Overview
15.5.5 BioFarma Recent Developments
15.6 GreenSignal Bio Pharma
15.6.1 GreenSignal Bio Pharma Basic Information
15.6.2 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Overview
15.6.3 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Market Performance
15.6.4 GreenSignal Bio Pharma Business Overview
15.6.5 GreenSignal Bio Pharma Recent Developments
15.7 China National Biotec
15.7.1 China National Biotec Basic Information
15.7.2 China National Biotec BCG and Tuberculosis Vaccine Product Overview
15.7.3 China National Biotec BCG and Tuberculosis Vaccine Product Market Performance
15.7.4 China National Biotec Business Overview
15.7.5 China National Biotec Recent Developments
15.8 Biomed Lublin
15.8.1 Biomed Lublin Basic Information
15.8.2 Biomed Lublin BCG and Tuberculosis Vaccine Product Overview
15.8.3 Biomed Lublin BCG and Tuberculosis Vaccine Product Market Performance
15.8.4 Biomed Lublin Business Overview
15.8.5 Biomed Lublin Recent Developments
15.9 Taj Pharmaceuticals
15.9.1 Taj Pharmaceuticals Basic Information
15.9.2 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Overview
15.9.3 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Market Performance
15.9.4 Taj Pharmaceuticals Business Overview
15.9.5 Taj Pharmaceuticals Recent Developments
15.10 Ataulpho de Paiva
15.10.1 Ataulpho de Paiva Basic Information
15.10.2 Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Overview
15.10.3 Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Market Performance
15.10.4 Ataulpho de Paiva Business Overview
15.10.5 Ataulpho de Paiva Recent Developments
15.11 IVAC-Institute of Vaccines and Medical Biologicals
15.11.1 IVAC-Institute of Vaccines and Medical Biologicals Basic Information
15.11.2 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Overview
15.11.3 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Market Performance
15.11.4 IVAC-Institute of Vaccines and Medical Biologicals Business Overview
15.11.5 IVAC-Institute of Vaccines and Medical Biologicals Recent Developments
15.12 Queen Saovabha Mem. Inst
15.12.1 Queen Saovabha Mem. Inst Basic Information
15.12.2 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Overview
15.12.3 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Market Performance
15.12.4 Queen Saovabha Mem. Inst Business Overview
15.12.5 Queen Saovabha Mem. Inst Recent Developments
15.13 Microgen
15.13.1 Microgen Basic Information
15.13.2 Microgen BCG and Tuberculosis Vaccine Product Overview
15.13.3 Microgen BCG and Tuberculosis Vaccine Product Market Performance
15.13.4 Microgen Business Overview
15.13.5 Microgen Recent Developments
16 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of BCG and Tuberculosis Vaccine
1.2 Key Market Segments
1.2.1 BCG and Tuberculosis Vaccine Segment by Type
1.2.2 BCG and Tuberculosis Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL BCG AND TUBERCULOSIS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global BCG and Tuberculosis Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global BCG and Tuberculosis Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL BCG AND TUBERCULOSIS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global BCG and Tuberculosis Vaccine Product Life Cycle
3.3 Global BCG and Tuberculosis Vaccine Sales by Manufacturers (2020-2025)
3.4 Global BCG and Tuberculosis Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 BCG and Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global BCG and Tuberculosis Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers BCG and Tuberculosis Vaccine Manufacturing Sites, Area Served, Product Type
3.8 BCG and Tuberculosis Vaccine Market Competitive Situation and Trends
3.8.1 BCG and Tuberculosis Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest BCG and Tuberculosis Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BCG AND TUBERCULOSIS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 BCG and Tuberculosis Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BCG AND TUBERCULOSIS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global BCG and Tuberculosis Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to BCG and Tuberculosis Vaccine Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL BCG AND TUBERCULOSIS VACCINE MARKET BY REGION
6.1 Global BCG and Tuberculosis Vaccine Market Size by Region
6.1.1 Global BCG and Tuberculosis Vaccine Market Size by Region
6.1.2 Global BCG and Tuberculosis Vaccine Market Size Market Share by Region
6.2 Global BCG and Tuberculosis Vaccine Sales by Region
6.2.1 Global BCG and Tuberculosis Vaccine Sales by Region
6.2.2 Global BCG and Tuberculosis Vaccine Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America BCG and Tuberculosis Vaccine Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America BCG and Tuberculosis Vaccine Market Size by Type
7.3 North America BCG and Tuberculosis Vaccine Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe BCG and Tuberculosis Vaccine Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe BCG and Tuberculosis Vaccine Market Size by Type
8.3 Europe BCG and Tuberculosis Vaccine Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific BCG and Tuberculosis Vaccine Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific BCG and Tuberculosis Vaccine Market Size by Type
9.3 Asia-Pacific BCG and Tuberculosis Vaccine Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America BCG and Tuberculosis Vaccine Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America BCG and Tuberculosis Vaccine Market Size by Type
10.3 South America BCG and Tuberculosis Vaccine Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Type
11.3 Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Application
12 BCG AND TUBERCULOSIS VACCINE MARKET PRODUCTION BY REGION
12.1 Global Production of BCG and Tuberculosis Vaccine by Region(2020-2025)
12.2 Global BCG and Tuberculosis Vaccine Revenue Market Share by Region (2020-2025)
12.3 Global BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America BCG and Tuberculosis Vaccine Production
12.4.1 North America BCG and Tuberculosis Vaccine Production Growth Rate (2020-2025)
12.4.2 North America BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe BCG and Tuberculosis Vaccine Production
12.5.1 Europe BCG and Tuberculosis Vaccine Production Growth Rate (2020-2025)
12.5.2 Europe BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan BCG and Tuberculosis Vaccine Production (2020-2025)
12.6.1 Japan BCG and Tuberculosis Vaccine Production Growth Rate (2020-2025)
12.6.2 Japan BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China BCG and Tuberculosis Vaccine Production (2020-2025)
12.7.1 China BCG and Tuberculosis Vaccine Production Growth Rate (2020-2025)
12.7.2 China BCG and Tuberculosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
13 BCG AND TUBERCULOSIS VACCINE MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2020-2033)
13.3 Global BCG and Tuberculosis Vaccine Market Size Market Share by Type (2020-2033)
13.4 Global BCG and Tuberculosis Vaccine Price by Type (2020-2033)
14 BCG AND TUBERCULOSIS VACCINE MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global BCG and Tuberculosis Vaccine Market Sales by Application (2020-2033)
14.3 Global BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2033)
14.4 Global BCG and Tuberculosis Vaccine Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Merck
15.1.1 Merck Basic Information
15.1.2 Merck BCG and Tuberculosis Vaccine Product Overview
15.1.3 Merck BCG and Tuberculosis Vaccine Product Market Performance
15.1.4 Merck Business Overview
15.1.5 Merck SWOT Analysis
15.1.6 Merck Recent Developments
15.2 Japan BCG Lab
15.2.1 Japan BCG Lab Basic Information
15.2.2 Japan BCG Lab BCG and Tuberculosis Vaccine Product Overview
15.2.3 Japan BCG Lab BCG and Tuberculosis Vaccine Product Market Performance
15.2.4 Japan BCG Lab Business Overview
15.2.5 Japan BCG Lab SWOT Analysis
15.2.6 Japan BCG Lab Recent Developments
15.3 Serum Institute of India
15.3.1 Serum Institute of India Basic Information
15.3.2 Serum Institute of India BCG and Tuberculosis Vaccine Product Overview
15.3.3 Serum Institute of India BCG and Tuberculosis Vaccine Product Market Performance
15.3.4 Serum Institute of India Business Overview
15.3.5 Serum Institute of India SWOT Analysis
15.3.6 Serum Institute of India Recent Developments
15.4 AJ Vaccines
15.4.1 AJ Vaccines Basic Information
15.4.2 AJ Vaccines BCG and Tuberculosis Vaccine Product Overview
15.4.3 AJ Vaccines BCG and Tuberculosis Vaccine Product Market Performance
15.4.4 AJ Vaccines Business Overview
15.4.5 AJ Vaccines Recent Developments
15.5 BioFarma
15.5.1 BioFarma Basic Information
15.5.2 BioFarma BCG and Tuberculosis Vaccine Product Overview
15.5.3 BioFarma BCG and Tuberculosis Vaccine Product Market Performance
15.5.4 BioFarma Business Overview
15.5.5 BioFarma Recent Developments
15.6 GreenSignal Bio Pharma
15.6.1 GreenSignal Bio Pharma Basic Information
15.6.2 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Overview
15.6.3 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Market Performance
15.6.4 GreenSignal Bio Pharma Business Overview
15.6.5 GreenSignal Bio Pharma Recent Developments
15.7 China National Biotec
15.7.1 China National Biotec Basic Information
15.7.2 China National Biotec BCG and Tuberculosis Vaccine Product Overview
15.7.3 China National Biotec BCG and Tuberculosis Vaccine Product Market Performance
15.7.4 China National Biotec Business Overview
15.7.5 China National Biotec Recent Developments
15.8 Biomed Lublin
15.8.1 Biomed Lublin Basic Information
15.8.2 Biomed Lublin BCG and Tuberculosis Vaccine Product Overview
15.8.3 Biomed Lublin BCG and Tuberculosis Vaccine Product Market Performance
15.8.4 Biomed Lublin Business Overview
15.8.5 Biomed Lublin Recent Developments
15.9 Taj Pharmaceuticals
15.9.1 Taj Pharmaceuticals Basic Information
15.9.2 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Overview
15.9.3 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Market Performance
15.9.4 Taj Pharmaceuticals Business Overview
15.9.5 Taj Pharmaceuticals Recent Developments
15.10 Ataulpho de Paiva
15.10.1 Ataulpho de Paiva Basic Information
15.10.2 Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Overview
15.10.3 Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Market Performance
15.10.4 Ataulpho de Paiva Business Overview
15.10.5 Ataulpho de Paiva Recent Developments
15.11 IVAC-Institute of Vaccines and Medical Biologicals
15.11.1 IVAC-Institute of Vaccines and Medical Biologicals Basic Information
15.11.2 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Overview
15.11.3 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Market Performance
15.11.4 IVAC-Institute of Vaccines and Medical Biologicals Business Overview
15.11.5 IVAC-Institute of Vaccines and Medical Biologicals Recent Developments
15.12 Queen Saovabha Mem. Inst
15.12.1 Queen Saovabha Mem. Inst Basic Information
15.12.2 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Overview
15.12.3 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Market Performance
15.12.4 Queen Saovabha Mem. Inst Business Overview
15.12.5 Queen Saovabha Mem. Inst Recent Developments
15.13 Microgen
15.13.1 Microgen Basic Information
15.13.2 Microgen BCG and Tuberculosis Vaccine Product Overview
15.13.3 Microgen BCG and Tuberculosis Vaccine Product Market Performance
15.13.4 Microgen Business Overview
15.13.5 Microgen Recent Developments
16 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 4. Global BCG and Tuberculosis Vaccine Market Size by Application (M USD)
Table 5. BCG and Tuberculosis Vaccine Market Size Comparison by Region (M USD)
Table 6. Global BCG and Tuberculosis Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global BCG and Tuberculosis Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global BCG and Tuberculosis Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global BCG and Tuberculosis Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG and Tuberculosis Vaccine as of 2024)
Table 11. Global Market BCG and Tuberculosis Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers BCG and Tuberculosis Vaccine Manufacturing Sites and Area Served
Table 13. Manufacturers BCG and Tuberculosis Vaccine Product Type
Table 14. Global BCG and Tuberculosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. BCG and Tuberculosis Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. BCG and Tuberculosis Vaccine Market Size Comparison by Region (M USD)
Table 26. Global BCG and Tuberculosis Vaccine Market Size by Region (2020-2033) & (M USD)
Table 27. Global BCG and Tuberculosis Vaccine Market Size Market Share by Region (2020-2033)
Table 28. Global BCG and Tuberculosis Vaccine Sales by Region (2020-2033) & (K MT)
Table 29. Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2020-2033)
Table 30. North America BCG and Tuberculosis Vaccine Market Size by Country (2020-2033) & (M USD)
Table 31. North America BCG and Tuberculosis Vaccine Sales by Country (2020-2033) & (K MT)
Table 32. North America BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 33. North America BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 34. North America BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2033)
Table 35. North America BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2033)
Table 36. North America BCG and Tuberculosis Vaccine Sales by Application (K MT)
Table 37. North America BCG and Tuberculosis Vaccine Market Size by Application (M USD)
Table 38. North America BCG and Tuberculosis Vaccine Sales (K MT) by Application (2020-2033)
Table 39. North America BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2033)
Table 40. Europe BCG and Tuberculosis Vaccine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe BCG and Tuberculosis Vaccine Sales by Country (2020-2033) & (K MT)
Table 42. Europe BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 43. Europe BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 44. Europe BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2033)
Table 45. Europe BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2033)
Table 46. Europe BCG and Tuberculosis Vaccine Sales by Application (K MT)
Table 47. Europe BCG and Tuberculosis Vaccine Market Size by Application (M USD)
Table 48. Europe BCG and Tuberculosis Vaccine Sales (K MT) by Application (2020-2033)
Table 49. Europe BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific BCG and Tuberculosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific BCG and Tuberculosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 53. Asia-Pacific BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 54. Asia-Pacific BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific BCG and Tuberculosis Vaccine Sales by Application (K MT)
Table 57. Asia-Pacific BCG and Tuberculosis Vaccine Market Size by Application (M USD)
Table 58. Asia-Pacific BCG and Tuberculosis Vaccine Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2025)
Table 60. South America BCG and Tuberculosis Vaccine Market Size by Country (2020-2033) & (M USD)
Table 61. South America BCG and Tuberculosis Vaccine Sales by Country (2020-2033) & (K MT)
Table 62. South America BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 63. South America BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 64. South America BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2033)
Table 65. South America BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2033)
Table 66. South America BCG and Tuberculosis Vaccine Sales by Application (K MT)
Table 67. South America BCG and Tuberculosis Vaccine Market Size by Application (M USD)
Table 68. South America BCG and Tuberculosis Vaccine Sales (K MT) by Application (2020-2033)
Table 69. South America BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa BCG and Tuberculosis Vaccine Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 73. Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 74. Middle East and Africa BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa BCG and Tuberculosis Vaccine Sales by Application (K MT)
Table 77. Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Application (M USD)
Table 78. Middle East and Africa BCG and Tuberculosis Vaccine Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2033)
Table 80. Global BCG and Tuberculosis Vaccine Production (K MT) by Region(2020-2025)
Table 81. Global BCG and Tuberculosis Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global BCG and Tuberculosis Vaccine Revenue Market Share by Region (2020-2025)
Table 83. Global BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 89. Global BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 90. Global BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2033)
Table 91. Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2020-2033)
Table 92. Global BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2033)
Table 93. Global BCG and Tuberculosis Vaccine Market Size Share by Type (2020-2033)
Table 94. Global BCG and Tuberculosis Vaccine Sales (K MT) by Application
Table 95. Global BCG and Tuberculosis Vaccine Market Size by Application(M USD)
Table 96. Global BCG and Tuberculosis Vaccine Sales by Application (2020-2033) & (K MT)
Table 97. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2020-2033)
Table 98. Global BCG and Tuberculosis Vaccine Market Size by Application (2020-2033) & (M USD)
Table 99. Global BCG and Tuberculosis Vaccine Market Share by Application (2020-2033)
Table 100. Global BCG and Tuberculosis Vaccine Sales Growth Rate by Application (2020-2033)
Table 101. Merck Basic Information
Table 102. Merck BCG and Tuberculosis Vaccine Product Overview
Table 103. Merck BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Merck Business Overview
Table 105. Merck SWOT Analysis
Table 106. Merck Recent Developments
Table 107. Japan BCG Lab Basic Information
Table 108. Japan BCG Lab BCG and Tuberculosis Vaccine Product Overview
Table 109. Japan BCG Lab BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Japan BCG Lab Business Overview
Table 111. Japan BCG Lab SWOT Analysis
Table 112. Japan BCG Lab Recent Developments
Table 113. Serum Institute of India Basic Information
Table 114. Serum Institute of India BCG and Tuberculosis Vaccine Product Overview
Table 115. Serum Institute of India BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Serum Institute of India Business Overview
Table 117. Serum Institute of India SWOT Analysis
Table 118. Serum Institute of India Recent Developments
Table 119. AJ Vaccines Basic Information
Table 120. AJ Vaccines BCG and Tuberculosis Vaccine Product Overview
Table 121. AJ Vaccines BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. AJ Vaccines Business Overview
Table 123. AJ Vaccines Recent Developments
Table 124. BioFarma Basic Information
Table 125. BioFarma BCG and Tuberculosis Vaccine Product Overview
Table 126. BioFarma BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. BioFarma Business Overview
Table 128. BioFarma Recent Developments
Table 129. GreenSignal Bio Pharma Basic Information
Table 130. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Overview
Table 131. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. GreenSignal Bio Pharma Business Overview
Table 133. GreenSignal Bio Pharma Recent Developments
Table 134. China National Biotec Basic Information
Table 135. China National Biotec BCG and Tuberculosis Vaccine Product Overview
Table 136. China National Biotec BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. China National Biotec Business Overview
Table 138. China National Biotec Recent Developments
Table 139. Biomed Lublin Basic Information
Table 140. Biomed Lublin BCG and Tuberculosis Vaccine Product Overview
Table 141. Biomed Lublin BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Biomed Lublin Business Overview
Table 143. Biomed Lublin Recent Developments
Table 144. Taj Pharmaceuticals Basic Information
Table 145. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Overview
Table 146. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Taj Pharmaceuticals Business Overview
Table 148. Taj Pharmaceuticals Recent Developments
Table 149. Ataulpho de Paiva Basic Information
Table 150. Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Overview
Table 151. Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Ataulpho de Paiva Business Overview
Table 153. Ataulpho de Paiva Recent Developments
Table 154. IVAC-Institute of Vaccines and Medical Biologicals Basic Information
Table 155. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Overview
Table 156. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. IVAC-Institute of Vaccines and Medical Biologicals Business Overview
Table 158. IVAC-Institute of Vaccines and Medical Biologicals Recent Developments
Table 159. Queen Saovabha Mem. Inst Basic Information
Table 160. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Overview
Table 161. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Queen Saovabha Mem. Inst Business Overview
Table 163. Queen Saovabha Mem. Inst Recent Developments
Table 164. Microgen Basic Information
Table 165. Microgen BCG and Tuberculosis Vaccine Product Overview
Table 166. Microgen BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Microgen Business Overview
Table 168. Microgen Recent Developments
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 4. Global BCG and Tuberculosis Vaccine Market Size by Application (M USD)
Table 5. BCG and Tuberculosis Vaccine Market Size Comparison by Region (M USD)
Table 6. Global BCG and Tuberculosis Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global BCG and Tuberculosis Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global BCG and Tuberculosis Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global BCG and Tuberculosis Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG and Tuberculosis Vaccine as of 2024)
Table 11. Global Market BCG and Tuberculosis Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers BCG and Tuberculosis Vaccine Manufacturing Sites and Area Served
Table 13. Manufacturers BCG and Tuberculosis Vaccine Product Type
Table 14. Global BCG and Tuberculosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. BCG and Tuberculosis Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. BCG and Tuberculosis Vaccine Market Size Comparison by Region (M USD)
Table 26. Global BCG and Tuberculosis Vaccine Market Size by Region (2020-2033) & (M USD)
Table 27. Global BCG and Tuberculosis Vaccine Market Size Market Share by Region (2020-2033)
Table 28. Global BCG and Tuberculosis Vaccine Sales by Region (2020-2033) & (K MT)
Table 29. Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2020-2033)
Table 30. North America BCG and Tuberculosis Vaccine Market Size by Country (2020-2033) & (M USD)
Table 31. North America BCG and Tuberculosis Vaccine Sales by Country (2020-2033) & (K MT)
Table 32. North America BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 33. North America BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 34. North America BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2033)
Table 35. North America BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2033)
Table 36. North America BCG and Tuberculosis Vaccine Sales by Application (K MT)
Table 37. North America BCG and Tuberculosis Vaccine Market Size by Application (M USD)
Table 38. North America BCG and Tuberculosis Vaccine Sales (K MT) by Application (2020-2033)
Table 39. North America BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2033)
Table 40. Europe BCG and Tuberculosis Vaccine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe BCG and Tuberculosis Vaccine Sales by Country (2020-2033) & (K MT)
Table 42. Europe BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 43. Europe BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 44. Europe BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2033)
Table 45. Europe BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2033)
Table 46. Europe BCG and Tuberculosis Vaccine Sales by Application (K MT)
Table 47. Europe BCG and Tuberculosis Vaccine Market Size by Application (M USD)
Table 48. Europe BCG and Tuberculosis Vaccine Sales (K MT) by Application (2020-2033)
Table 49. Europe BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific BCG and Tuberculosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific BCG and Tuberculosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 53. Asia-Pacific BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 54. Asia-Pacific BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific BCG and Tuberculosis Vaccine Sales by Application (K MT)
Table 57. Asia-Pacific BCG and Tuberculosis Vaccine Market Size by Application (M USD)
Table 58. Asia-Pacific BCG and Tuberculosis Vaccine Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2025)
Table 60. South America BCG and Tuberculosis Vaccine Market Size by Country (2020-2033) & (M USD)
Table 61. South America BCG and Tuberculosis Vaccine Sales by Country (2020-2033) & (K MT)
Table 62. South America BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 63. South America BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 64. South America BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2033)
Table 65. South America BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2033)
Table 66. South America BCG and Tuberculosis Vaccine Sales by Application (K MT)
Table 67. South America BCG and Tuberculosis Vaccine Market Size by Application (M USD)
Table 68. South America BCG and Tuberculosis Vaccine Sales (K MT) by Application (2020-2033)
Table 69. South America BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa BCG and Tuberculosis Vaccine Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 73. Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 74. Middle East and Africa BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa BCG and Tuberculosis Vaccine Sales by Application (K MT)
Table 77. Middle East and Africa BCG and Tuberculosis Vaccine Market Size by Application (M USD)
Table 78. Middle East and Africa BCG and Tuberculosis Vaccine Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa BCG and Tuberculosis Vaccine Market Size (M USD) by Application (2020-2033)
Table 80. Global BCG and Tuberculosis Vaccine Production (K MT) by Region(2020-2025)
Table 81. Global BCG and Tuberculosis Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global BCG and Tuberculosis Vaccine Revenue Market Share by Region (2020-2025)
Table 83. Global BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China BCG and Tuberculosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global BCG and Tuberculosis Vaccine Sales by Type (K MT)
Table 89. Global BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Table 90. Global BCG and Tuberculosis Vaccine Sales (K MT) by Type (2020-2033)
Table 91. Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2020-2033)
Table 92. Global BCG and Tuberculosis Vaccine Market Size (M USD) by Type (2020-2033)
Table 93. Global BCG and Tuberculosis Vaccine Market Size Share by Type (2020-2033)
Table 94. Global BCG and Tuberculosis Vaccine Sales (K MT) by Application
Table 95. Global BCG and Tuberculosis Vaccine Market Size by Application(M USD)
Table 96. Global BCG and Tuberculosis Vaccine Sales by Application (2020-2033) & (K MT)
Table 97. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2020-2033)
Table 98. Global BCG and Tuberculosis Vaccine Market Size by Application (2020-2033) & (M USD)
Table 99. Global BCG and Tuberculosis Vaccine Market Share by Application (2020-2033)
Table 100. Global BCG and Tuberculosis Vaccine Sales Growth Rate by Application (2020-2033)
Table 101. Merck Basic Information
Table 102. Merck BCG and Tuberculosis Vaccine Product Overview
Table 103. Merck BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Merck Business Overview
Table 105. Merck SWOT Analysis
Table 106. Merck Recent Developments
Table 107. Japan BCG Lab Basic Information
Table 108. Japan BCG Lab BCG and Tuberculosis Vaccine Product Overview
Table 109. Japan BCG Lab BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Japan BCG Lab Business Overview
Table 111. Japan BCG Lab SWOT Analysis
Table 112. Japan BCG Lab Recent Developments
Table 113. Serum Institute of India Basic Information
Table 114. Serum Institute of India BCG and Tuberculosis Vaccine Product Overview
Table 115. Serum Institute of India BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Serum Institute of India Business Overview
Table 117. Serum Institute of India SWOT Analysis
Table 118. Serum Institute of India Recent Developments
Table 119. AJ Vaccines Basic Information
Table 120. AJ Vaccines BCG and Tuberculosis Vaccine Product Overview
Table 121. AJ Vaccines BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. AJ Vaccines Business Overview
Table 123. AJ Vaccines Recent Developments
Table 124. BioFarma Basic Information
Table 125. BioFarma BCG and Tuberculosis Vaccine Product Overview
Table 126. BioFarma BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. BioFarma Business Overview
Table 128. BioFarma Recent Developments
Table 129. GreenSignal Bio Pharma Basic Information
Table 130. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Overview
Table 131. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. GreenSignal Bio Pharma Business Overview
Table 133. GreenSignal Bio Pharma Recent Developments
Table 134. China National Biotec Basic Information
Table 135. China National Biotec BCG and Tuberculosis Vaccine Product Overview
Table 136. China National Biotec BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. China National Biotec Business Overview
Table 138. China National Biotec Recent Developments
Table 139. Biomed Lublin Basic Information
Table 140. Biomed Lublin BCG and Tuberculosis Vaccine Product Overview
Table 141. Biomed Lublin BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Biomed Lublin Business Overview
Table 143. Biomed Lublin Recent Developments
Table 144. Taj Pharmaceuticals Basic Information
Table 145. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Overview
Table 146. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Taj Pharmaceuticals Business Overview
Table 148. Taj Pharmaceuticals Recent Developments
Table 149. Ataulpho de Paiva Basic Information
Table 150. Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Overview
Table 151. Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Ataulpho de Paiva Business Overview
Table 153. Ataulpho de Paiva Recent Developments
Table 154. IVAC-Institute of Vaccines and Medical Biologicals Basic Information
Table 155. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Overview
Table 156. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. IVAC-Institute of Vaccines and Medical Biologicals Business Overview
Table 158. IVAC-Institute of Vaccines and Medical Biologicals Recent Developments
Table 159. Queen Saovabha Mem. Inst Basic Information
Table 160. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Overview
Table 161. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Queen Saovabha Mem. Inst Business Overview
Table 163. Queen Saovabha Mem. Inst Recent Developments
Table 164. Microgen Basic Information
Table 165. Microgen BCG and Tuberculosis Vaccine Product Overview
Table 166. Microgen BCG and Tuberculosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Microgen Business Overview
Table 168. Microgen Recent Developments
LIST OF FIGURES
Figure 1. Product Picture of BCG and Tuberculosis Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global BCG and Tuberculosis Vaccine Market Size (M USD), 2024-2033
Figure 5. Global BCG and Tuberculosis Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global BCG and Tuberculosis Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. BCG and Tuberculosis Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global BCG and Tuberculosis Vaccine Product Life Cycle
Figure 13. BCG and Tuberculosis Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global BCG and Tuberculosis Vaccine Revenue Share by Manufacturers in 2024
Figure 15. BCG and Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market BCG and Tuberculosis Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by BCG and Tuberculosis Vaccine Revenue in 2024
Figure 18. Industry Chain Map of BCG and Tuberculosis Vaccine
Figure 19. Global BCG and Tuberculosis Vaccine Market PEST Analysis
Figure 20. Global BCG and Tuberculosis Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global BCG and Tuberculosis Vaccine Market Size by Region
Figure 27. Global BCG and Tuberculosis Vaccine Market Size Market Share by Region (2020-2033)
Figure 28. Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America BCG and Tuberculosis Vaccine Market Size (M USD) by Country
Figure 33. USA BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada BCG and Tuberculosis Vaccine Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada BCG and Tuberculosis Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico BCG and Tuberculosis Vaccine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico BCG and Tuberculosis Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America BCG and Tuberculosis Vaccine Market Size (M USD)by Type
Figure 40. North America BCG and Tuberculosis Vaccine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe BCG and Tuberculosis Vaccine Market Size (M USD) by Country
Figure 45. Germany BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe BCG and Tuberculosis Vaccine Market Size (M USD) by Type
Figure 56. Europe BCG and Tuberculosis Vaccine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific BCG and Tuberculosis Vaccine Market Size (M USD) by Country
Figure 61. China BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific BCG and Tuberculosis Vaccine Market Size (M USD) by Type
Figure 72. Asia-Pacific BCG and Tuberculosis Vaccine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America BCG and Tuberculosis Vaccine Market Size (M USD) by Country
Figure 77. Brazil BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America BCG and Tuberculosis Vaccine Market Size (M USD) by Type
Figure 84. South America BCG and Tuberculosis Vaccine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa BCG and Tuberculosis Vaccine Market Size (M USD) by Country
Figure 89. Saudi Arabia BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa BCG and Tuberculosis Vaccine Market Size (M USD) by Type
Figure 100. Middle East and Africa BCG and Tuberculosis Vaccine Market Size (M USD) by Application
Figure 101. Global BCG and Tuberculosis Vaccine Production Market Share by Region (2020-2025)
Figure 102. North America BCG and Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe BCG and Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan BCG and Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. China BCG and Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Figure 108. Sales Market Share of BCG and Tuberculosis Vaccine by Type (2020-2033)
Figure 109. Sales Market Share of BCG and Tuberculosis Vaccine by Type in 2024
Figure 110. Market Size Share of BCG and Tuberculosis Vaccine by Type (2020-2033)
Figure 111. Market Size Share of BCG and Tuberculosis Vaccine by Type in 2024
Figure 112. Global BCG and Tuberculosis Vaccine Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global BCG and Tuberculosis Vaccine Market Size by Application(M USD)
Figure 115. Global BCG and Tuberculosis Vaccine Market Share by Application
Figure 116. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2020-2033)
Figure 117. Global BCG and Tuberculosis Vaccine Sales Market Share by Application in 2024
Figure 118. Global BCG and Tuberculosis Vaccine Market Share by Application (2020-2033)
Figure 119. Global BCG and Tuberculosis Vaccine Market Share by Application in 2024
Figure 120. Global BCG and Tuberculosis Vaccine Sales Growth Rate by Application (2020-2033)
Figure 1. Product Picture of BCG and Tuberculosis Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global BCG and Tuberculosis Vaccine Market Size (M USD), 2024-2033
Figure 5. Global BCG and Tuberculosis Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global BCG and Tuberculosis Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. BCG and Tuberculosis Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global BCG and Tuberculosis Vaccine Product Life Cycle
Figure 13. BCG and Tuberculosis Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global BCG and Tuberculosis Vaccine Revenue Share by Manufacturers in 2024
Figure 15. BCG and Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market BCG and Tuberculosis Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by BCG and Tuberculosis Vaccine Revenue in 2024
Figure 18. Industry Chain Map of BCG and Tuberculosis Vaccine
Figure 19. Global BCG and Tuberculosis Vaccine Market PEST Analysis
Figure 20. Global BCG and Tuberculosis Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global BCG and Tuberculosis Vaccine Market Size by Region
Figure 27. Global BCG and Tuberculosis Vaccine Market Size Market Share by Region (2020-2033)
Figure 28. Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America BCG and Tuberculosis Vaccine Market Size (M USD) by Country
Figure 33. USA BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada BCG and Tuberculosis Vaccine Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada BCG and Tuberculosis Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico BCG and Tuberculosis Vaccine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico BCG and Tuberculosis Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America BCG and Tuberculosis Vaccine Market Size (M USD)by Type
Figure 40. North America BCG and Tuberculosis Vaccine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe BCG and Tuberculosis Vaccine Market Size (M USD) by Country
Figure 45. Germany BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe BCG and Tuberculosis Vaccine Market Size (M USD) by Type
Figure 56. Europe BCG and Tuberculosis Vaccine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific BCG and Tuberculosis Vaccine Market Size (M USD) by Country
Figure 61. China BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific BCG and Tuberculosis Vaccine Market Size (M USD) by Type
Figure 72. Asia-Pacific BCG and Tuberculosis Vaccine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America BCG and Tuberculosis Vaccine Market Size (M USD) by Country
Figure 77. Brazil BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America BCG and Tuberculosis Vaccine Market Size (M USD) by Type
Figure 84. South America BCG and Tuberculosis Vaccine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa BCG and Tuberculosis Vaccine Market Size (M USD) by Country
Figure 89. Saudi Arabia BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa BCG and Tuberculosis Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa BCG and Tuberculosis Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa BCG and Tuberculosis Vaccine Market Size (M USD) by Type
Figure 100. Middle East and Africa BCG and Tuberculosis Vaccine Market Size (M USD) by Application
Figure 101. Global BCG and Tuberculosis Vaccine Production Market Share by Region (2020-2025)
Figure 102. North America BCG and Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe BCG and Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan BCG and Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. China BCG and Tuberculosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global BCG and Tuberculosis Vaccine Market Size by Type (M USD)
Figure 108. Sales Market Share of BCG and Tuberculosis Vaccine by Type (2020-2033)
Figure 109. Sales Market Share of BCG and Tuberculosis Vaccine by Type in 2024
Figure 110. Market Size Share of BCG and Tuberculosis Vaccine by Type (2020-2033)
Figure 111. Market Size Share of BCG and Tuberculosis Vaccine by Type in 2024
Figure 112. Global BCG and Tuberculosis Vaccine Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global BCG and Tuberculosis Vaccine Market Size by Application(M USD)
Figure 115. Global BCG and Tuberculosis Vaccine Market Share by Application
Figure 116. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2020-2033)
Figure 117. Global BCG and Tuberculosis Vaccine Sales Market Share by Application in 2024
Figure 118. Global BCG and Tuberculosis Vaccine Market Share by Application (2020-2033)
Figure 119. Global BCG and Tuberculosis Vaccine Market Share by Application in 2024
Figure 120. Global BCG and Tuberculosis Vaccine Sales Growth Rate by Application (2020-2033)
